Skip to main content
Veterinary Medicines

Gentaveto-5 50 mg/ml Oplossing voor injectie

Authorised
  • Gentamicin sulfate

Product identification

Medicine name:
Gentaveto-5 50 mg/ml Oplossing voor injectie
Gentaveto-5 50 mg/ml Solution injectable
Gentaveto-5 50 mg/ml Injektionslösung
Active substance:
  • Gentamicin sulfate
Target species:
  • Pig
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Gentamicin sulfate
    84.70
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Pig
      • Meat and offal
        146
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01GB03
Authorisation status:
  • Valid
Authorised in:
  • Belgium
Available in:
  • Belgium
Package description:
  • Gentaveto-5 100 ml Vial Solution for injection
  • Gentaveto-5 50 ml Vial Solution for injection
  • Gentaveto-5 10 ml Vial Solution for injection

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • V.M.D.
Marketing authorisation date:
Manufacturing sites for batch release:
  • V.M.D.
Responsible authority:
  • Federal Agency For Medicines And Health Products
Authorisation number:
  • BE-V163466
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 22/03/2022
French (PDF)
Published on: 22/03/2022

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 22/03/2022
French (PDF)
Published on: 22/03/2022
German (PDF)
Published on: 22/03/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."